The drug ACTAMAX contains
one active pharmaceutical ingredient (API):
UNII OFG5EXG60L - RISEDRONATE SODIUM
Risedronic acid is a pyridinyl bisphosphonate that binds to bone hydroxyapatite and inhibits osteoclast-mediated bone resorption. The bone turnover is reduced while the osteoblast activity and bone mineralisation is preserved.
Read about Risedronic acid
This drug has been classified in the anatomical therapeutic chemical (ATC) classification
system as follows: